Jasper Therapeutics Inc (JSPR)

NASDAQ
3.140
+0.140(+4.67%)
After Hours
2.990
-0.150(-4.777%)
- Real-time Data
  • Volume:
    16,088
  • Day's Range:
    3.015 - 3.430
  • 52 wk Range:
    2.450 - 18.880

JSPR Overview

Prev. Close
3
Day's Range
3.015-3.43
Revenue
-
Open
3.015
52 wk Range
2.45-18.88
EPS
-5.48
Volume
16,088
Market Cap
118.93M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
65,764
P/E Ratio
-
Beta
-
1-Year Change
-68.31%
Shares Outstanding
37,876,285
Next Earnings Date
Aug 31, 2022
What is your sentiment on Jasper Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Jasper Therapeutics Inc News

Jasper Therapeutics Inc Company Profile

Jasper Therapeutics Inc Company Profile

Employees
25

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company’s lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellNeutralSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuySellStrong Sell
SummaryNeutralNeutralBuySellStrong Sell
  • JSPR (P) 0.00000000 16.41000000
    0
    • Sold #JSPR @ 16.41000000
      0
      • A buy recommendation is that valuable?
        0
        • Missed it...
          0
          • Same here
            0